BOTHELL, Wash. (AP) _ Seattle Genetics Inc. (SGEN) on Thursday reported a loss of $136.5 million in its first quarter.The Bothell, Washington-based company said it had a loss of 74 cents per share.The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.The biotechnology company posted revenue of $426.5 million in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $408.9 million.Seattle Genetics expects full-year revenue in the range of $1.67 billion to $1.75 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGEN at https://www.zacks.com/ap/SGEN